PengJi_lab Profile Banner
Peng Ji Profile
Peng Ji

@PengJi_lab

Followers
848
Following
3K
Media
46
Statuses
374

Physician scientist, Hematopathologist, Vice Chair of Research, Director of Pathology Physician Scientist Training Program

Chicago, IL
Joined August 2019
Don't wanna be here? Send us removal request.
@PengJi_lab
Peng Ji
11 days
Congratulations to Dr. Pan Wang who will present two oral abstracts in this year’s ASH meeting! #ASH2025
0
2
18
@NU_Pathology
Northwestern Pathology
18 days
Congratulations to our pediatric path fellow, Dr. Lydia Du, for winning the Harry B. Neustein Memorial Award for her platform presentation at the Fall Society for Pediatric Pathology meeting. We’re very proud of her! #PurplePath
0
3
21
@PengJi_lab
Peng Ji
1 month
Honored to be recognized!
@NU_Pathology
Northwestern Pathology
1 month
We are fortunate to provide Endowed Chairs to two of our phenomenal faculty, Drs. Lee Cooper and Peng Ji. Both are world-class investigators and highly deserving! #PurplePath
12
0
49
@NU_Pathology
Northwestern Pathology
1 month
Ever wondered what our residency application review process is like? Program Director @JaredAhrendsen is here to give a behind the scenes look! #PurplePath #PathMatch26
6
18
85
@PengJi_lab
Peng Ji
2 months
Really enjoyed the visit! Thanks @gcai1978 @MinaXu7 @yalepathology for the invitation!
@yalepathology
Yale Pathology
2 months
Many thanks to @PengJi_Lab of @NUFeinbergMed for presenting today’s #Pathology Grand Rounds on “The Role of Inflammation in the Evolution from Clonal Hematopoiesis to MDS & AML” Here’s Dr. Ji, center, w/hosts, @gcai1978, left, & @MinaXu7, both Professors of Pathology @YaleMed
1
0
13
@NU_Pathology
Northwestern Pathology
2 months
Congratulations to Dr. Barina Aqil, featured in the PathologyOutlines September Newsletter: “What’s New in Hematopathology 2025: Myeloid Neoplasms in the WHO 5th Edition and ICC” #PurplePath
0
3
15
@PengJi_lab
Peng Ji
2 months
RIP. Dr. Baltimore.
0
0
5
@NU_Pathology
Northwestern Pathology
2 months
Interested in a residency at Northwestern Pathology? Join our current residents for a Q&A on Thursday, September 11, 2025 from 4-5pm CST. Register here: https://t.co/0921VCNG7v
0
14
18
@LurieCancer
Lurie Cancer Center
3 months
A new study led by Lurie Cancer Center’s ⁦@PengJi_lab⁩ revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that can lead to #leukemia, per findings in ⁦@NatureComms#leusm
Tweet card summary image
news.feinberg.northwestern.edu
A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that may lead to leukemia, according to findings published...
2
7
22
@NU_Pathology
Northwestern Pathology
3 months
Our department cruised down the Chicago River for some well-deserved socializing and R&R. A bit of rain did not get in the way of a fun time for all! Big thanks to @citycruises for the great experience🚢
0
8
49
@PengJi_lab
Peng Ji
3 months
Our study establishes DDX41 as a G4 resolvase, essential for erythroid genome stability and suppressing the cGAS-STING pathway.
0
0
2
@PengJi_lab
Peng Ji
3 months
In parallel, genome instability also activates the cGas-Sting pathway, impairing survival, as cGas deficiency rescues the lethality of hematopoietic-specific Ddx41 knock-out mice.
1
0
2
@PengJi_lab
Peng Ji
3 months
G4 accumulation induces erythroid genome instability, ribosomal defects, and p53 upregulation. However, p53 deficiency does not rescue the embryonic death of Ddx41 hematopoietic-specific knockout mice.
1
0
2
@PengJi_lab
Peng Ji
3 months
DX41 deficiency induces a significant upregulation of G-quadruplexes (G4), which co-distribute with DDX41 on the erythroid genome. DDX41 directly binds to and resolves G4, which is significantly compromised in MN-associated DDX41 mutants.
1
0
2
@PengJi_lab
Peng Ji
3 months
In this work, we show that DDX41 is essential for erythropoiesis but dispensable for other hematopoietic lineages. Ddx41 knockout in early erythropoiesis is embryonically lethal, while knockout in late-stage terminal erythropoiesis allows mice to survive with normal blood counts
1
0
2
@PengJi_lab
Peng Ji
3 months
Deleterious germline DDX41 variants constitute the most common inherited predisposition disorder linked to myeloid neoplasms (MNs), yet their role in MNs remains unclear.
1
0
1
@PengJi_lab
Peng Ji
3 months
Delighted to share our recently published work on the role of DDX41 in resolving G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death. https://t.co/7gVvx087Fe @NatureComms
7
9
44
@NU_Pathology
Northwestern Pathology
3 months
We had a great time at the annual Association for Academic Pathology meeting in Denver this past weekend🔬 Nice to see some familiar faces! #AAPath
1
6
48
@jclinicalinvest
Journal of Clinical Investigation
4 months
ICYMI: Ameliorating myeloproliferative neoplasms with cyclosporin A in preclinical models— @PengJi_lab & team @NUFeinbergMed discover PPIL2 as a target of the JAK2/STAT5 pathway that promotes myeloproliferation through p53 degradation: https://t.co/oT8J1qRr3V
0
5
11